Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes
Open Access
- 1 August 2011
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 62 (3), 283-294
- https://doi.org/10.1111/j.1574-695x.2011.00816.x
Abstract
Fluoxetine, one of the selective serotonin reuptake inhibitors (SSRIs), has been found to possess immune modulation effects, in addition to its antidepressant effects. However, it remains unclear whether SSRIs can suppress the antigen-presenting function of dendritic cells (DCs). Therefore, Fluoxetine was applied to a co-culture of Aggregatibacter actinomycetemcomitans (Aa)-reactive T cells (×Aa-T) isolated from Aa-immunized mice and DCs. This resulted in the suppressed proliferation of ×Aa-T stimulated with Aa-antigen presentation by DCs. Specifically, Fluoxetine increased the extracellular 5-hydroxytryptamine (5-HT) in the ×Aa-T/DC co-culture, whereas exogenously applied 5-HT promoted T-cell proliferation in the ×Aa-T/DC co-culture, indicating that Fluoxetine-mediated suppression of ×Aa-T/DC responses cannot be attributed to extracellular 5-HT. Instead, Fluoxetine remarkably suppressed the expression of costimulatory molecule ICOS-L on DCs. Fluoxetine also promoted a greater proportion of CD86Low immature DCs than CD86High mature DCs, while maintaining the expression levels of CD80, MHC-class-II and PD-L1. These results suggested that Fluoxetine suppressed the ability of DCs to present bacterial antigens to T cells, and the resulting T-cell proliferation, in a SERT/5-HT-independent manner and that diminished expression of ICOS-L on DCs and increase of CD86Low immature DCs caused by Fluoxetine might be partially associated with Fluoxetine-mediated suppression of DC/T-cell responses.Keywords
This publication has 50 references indexed in Scilit:
- Follicular Helper CD4 T Cells (TFH)Annual Review of Immunology, 2011
- Expression of receptor activator of nuclear factor‐κB ligand by B cells in response to oral bacteriaOral Microbiology and Immunology, 2009
- Do Desipramine [10,11-Dihydro-5-[3-(methylamino) propyl]-5H-dibenz[b,f]azepine monohydrochloride] and Fluoxetine [N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-propan-1-amine] Ameliorate the Extent of Colonic Damage Induced by Acetic Acid in Rats?The Journal of pharmacology and experimental therapeutics, 2008
- Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twistsPeriodontology 2000, 2007
- The role of ICOS in the development of CD4 T cell help and the reactivation of memory T cellsEuropean Journal of Immunology, 2007
- Anti-inflammatory properties of desipramine and fluoxetineRespiratory Research, 2007
- Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptorBlood, 2006
- B and T Lymphocytes Are the Primary Sources of RANKL in the Bone Resorptive Lesion of Periodontal DiseaseThe American Journal of Pathology, 2006
- Analysis of costimulatory molecule expression on antigen-specific T and B cells during the induction of adjuvant-induced Th1 and Th2 type responsesVaccine, 2006
- Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrowHuman Immunology, 2004